Is a complete TLSI research report available?

No complete published report is available for TriSalus Life Sciences, Inc. (TLSI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TriSalus Life Sciences, Inc. (TLSI)

NASDAQ: TLSI · USD

$3.93

+0.13 (+3.4%)· Recorded snapshot

Market cap	242M
Revenue (ttm)	45.1M
Net income (ttm)	-57.2M
EPS (ttm)	-$1.15
Shares out	61.6M
Volume	73,880
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 45.1M
Net income (ttm): -57.2M
EPS (ttm): -$1.15
Market cap: 242M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001826667
Company name	TriSalus Life Sciences, Inc.
Country	United States
Country code	US
CUSIP number	89680M101
Earnings date	2026-11-10
Earnings time	bmo
Employees	102
Employees change	-8
Employees growth	-7.27%
Enterprise value	$230.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US89680M1018
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$242M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	No
Price	$3.93
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	TLSI
U.S. state	Colorado
Website	https://trisaluslifesci.com

Metric

Value

Amount currency

USD

CIK code

0001826667

Company name

TriSalus Life Sciences, Inc.

Country

United States

Country code

CUSIP number

89680M101

Earnings date

2026-11-10

Earnings time

bmo

Employees

102

Employees change

-8

Employees growth

-7.27%

Enterprise value

$230.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

In index

RUSSELL2000

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

US89680M1018

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$242M

Market cap category

Micro-Cap

Next earnings date

2026-11-10

Options

Price

$3.93

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

TLSI

U.S. state

Colorado

Website

https://trisaluslifesci.com

Metric	Value
Earnings yield	-29.21%
EV/Sales	4.93x
FCF / EV yield	-10.48%
FCF yield	-9.95%
Forward EV/Sales	3.28x
Forward P/S	3.46x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	35.66x
P/S ratio	5.19x
Price / tangible book value	35.72x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-29.21%

EV/Sales

4.93x

FCF / EV yield

-10.48%

FCF yield

-9.95%

Forward EV/Sales

3.28x

Forward P/S

3.46x

Industry forward P/E

19.81x

Industry P/E

39.28x

P/B ratio

35.66x

P/S ratio

5.19x

Price / tangible book value

35.72x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-67.68%
EBITDA margin	-66.44%
Gross margin	85.79%
Operating margin	-67.68%
Pretax margin	-62.56%
Profit margin	-62.59%
Profit per employee	$-561,265
Revenue per employee	$441,931
ROA	-36.75%
ROA (5Y)	-85.19%
ROCE	-59.5%
ROIC	-69.07%
SBC / revenue	23.75%
Tax / revenue	0.03%

Metric

Value

EBIT margin

-67.68%

EBITDA margin

-66.44%

Gross margin

85.79%

Operating margin

-67.68%

Pretax margin

-62.56%

Profit margin

-62.59%

Profit per employee

$-561,265

Revenue per employee

$441,931

ROA

-36.75%

ROA (5Y)

-85.19%

ROCE

-59.5%

ROIC

-69.07%

SBC / revenue

23.75%

Tax / revenue

0.03%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Gross profit growth	26.9%
Gross profit growth (Q)	5.19%
Gross profit growth 3Y	48.56%
Net income growth years	0
Revenue growth	25.25%
Revenue growth (Q)	1.73%
Revenue growth (QoQ)	28.18%
Revenue growth 3Y	45.13%
Revenue growth quarters	1
Revenue growth years	4

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

26.9%

Gross profit growth (Q)

5.19%

Gross profit growth 3Y

48.56%

Net income growth years

Revenue growth

25.25%

Revenue growth (Q)

1.73%

Revenue growth (QoQ)

28.18%

Revenue growth 3Y

45.13%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-480,000
Depreciation and amortization	$560,000
EBIT	$-30.5M
EBITDA	$-29.9M
EPS	$-1.15
FCF per share	$-0.38
Financing cash flow	$42.7M
Free cash flow	$-23.3M
Free cash flow minus SBC	$-34M
Gross profit	$38.7M
Income taxes	$13,000
Investing cash flow	$-440,000
Net borrowing	$-36,000
Net cash flow	$19.4M
Net income	$-57.2M
Operating cash flow minus SBC	$-33.5M
Operating income	$-30.5M
Revenue	$45.1M
Stock-based compensation	$10.7M

Metric

Value

Capital expenditures

$-480,000

Depreciation and amortization

$560,000

EBIT

$-30.5M

EBITDA

$-29.9M

EPS

$-1.15

FCF per share

$-0.38

Financing cash flow

$42.7M

Free cash flow

$-23.3M

Free cash flow minus SBC

$-34M

Gross profit

$38.7M

Income taxes

$13,000

Investing cash flow

$-440,000

Net borrowing

$-36,000

Net cash flow

$19.4M

Net income

$-57.2M

Operating cash flow minus SBC

$-33.5M

Operating income

$-30.5M

Revenue

$45.1M

Stock-based compensation

$10.7M

Metric	Value
Altman Z-Score	-4.86
Book value per share	$0.11
Debt / equity	5.26
Interest coverage	-5.23
Long-term assets	$2.7M
Long-term liabilities	$44.7M
Net cash (debt)	$11.9M
Net cash / market cap	5.07%
Net debt / equity	-1.81
Piotroski F-Score	3
Property, plant and equipment	$2.6M
Shareholders' equity	$6.6M
Tangible book value	$6.6M
Tangible book value per share	$0.11
Total assets	$62.4M
Total cash	$46.3M
Total debt	$34.4M
Total liabilities	$55.9M
WACC	7.67%

Metric

Value

Altman Z-Score

-4.86

Book value per share

$0.11

Debt / equity

5.26

Interest coverage

-5.23

Long-term assets

$2.7M

Long-term liabilities

$44.7M

Net cash (debt)

$11.9M

Net cash / market cap

5.07%

Net debt / equity

-1.81

Piotroski F-Score

Property, plant and equipment

$2.6M

Shareholders' equity

$6.6M

Tangible book value

$6.6M

Tangible book value per share

$0.11

Total assets

$62.4M

Total cash

$46.3M

Total debt

$34.4M

Total liabilities

$55.9M

WACC

7.67%

Metric	Value
Asset turnover	0.87
Current assets	$59.7M
Current liabilities	$11.2M
Current ratio	5.35
Inventory turnover	1.6
Net working capital	$2.5M
Quick ratio	4.72
Working capital	$48.6M
Working capital turnover	1.17

Metric

Value

Asset turnover

0.87

Current assets

$59.7M

Current liabilities

$11.2M

Current ratio

5.35

Inventory turnover

1.6

Net working capital

$2.5M

Quick ratio

4.72

Working capital

$48.6M

Working capital turnover

1.17

Metric	Value
Buyback yield / dilution	-73.15%
Dividend yield	0%
Shareholder yield	-73.15%

Metric

Value

Buyback yield / dilution

-73.15%

Dividend yield

Shareholder yield

-73.15%

Metric	Value
150-day SMA	$4.29
1D price change	3.42%
1M price change	-10.83%
1M total return	-10.83%
1W price change	5.74%
1W total return	5.74%
1Y price change	-22.91%
1Y return CAGR	-22.92%
1Y total return	-22.91%
20-day SMA	$3.93
200-day SMA	$4.42
3M price change	-10.42%
3M total return	-10.42%
3Y price change	-15.87%
3Y return CAGR	-5.6%
3Y total return	-15.87%
50-day SMA	$4.50
50-day SMA vs 200-day SMA	50over200
52-week high	$7.95
52-week high date	2025-12-22
52-week low	$2.20
52-week low date	2026-05-13
5Y price change	-61.03%
5Y return CAGR	-17.18%
5Y total return	-61.03%
6M price change	-14%
6M total return	-14%
All-time high	$16.24
All-time high date	2023-08-11
All-time low	$2.20
All-time low date	2026-05-13
Average true range (ATR)	$0.25
Average volume	145.9K
Beta (1Y)	2.45
Beta (2Y)	1.15
Beta (5Y)	0.47
Change from 52-week high	-50.57%
Change from 52-week low	78.64%
Change from all-time high	-76.17%
Change from all-time low	75.91%
Change from open	1.55%
Day's gap	1.84%
Dollar volume	$290,348
High price	$3.93
Low price	$3.82
Monthly RSI	42.03
Open price	$3.87
Position in 52-week range	100%
Premarket change	-1.84%
Premarket close	$3.80
Premarket price	$3.73
Previous close	$3.80
Price vs 150-day SMA	-9.79%
Price vs 20-day SMA	-1.45%
Price vs 200-day SMA	-12.52%
Price vs 50-day SMA	-13.9%
Relative volume	0.51
RSI	43.05
Sharpe ratio	0.06
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	-0.05
Sortino ratio	0.14
Sortino ratio (3Y)	0.37
Sortino ratio (5Y)	0.02
Volume	73.9K
Weekly RSI	44.21
YTD price change	-44.56%
YTD total return	-44.56%

Metric

Value

150-day SMA

$4.29

1D price change

3.42%

1M price change

-10.83%

1M total return

-10.83%

1W price change

5.74%

1W total return

5.74%

1Y price change

-22.91%

1Y return CAGR

-22.92%

1Y total return

-22.91%

20-day SMA

$3.93

200-day SMA

$4.42

3M price change

-10.42%

3M total return

-10.42%

3Y price change

-15.87%

3Y return CAGR

-5.6%

3Y total return

-15.87%

50-day SMA

$4.50

50-day SMA vs 200-day SMA

50over200

52-week high

$7.95

52-week high date

2025-12-22

52-week low

$2.20

52-week low date

2026-05-13

5Y price change

-61.03%

5Y return CAGR

-17.18%

5Y total return

-61.03%

6M price change

-14%

6M total return

-14%

All-time high

$16.24

All-time high date

2023-08-11

All-time low

$2.20

All-time low date

2026-05-13

Average true range (ATR)

$0.25

Average volume

145.9K

Beta (1Y)

2.45

Beta (2Y)

1.15

Beta (5Y)

0.47

Change from 52-week high

-50.57%

Change from 52-week low

78.64%

Change from all-time high

-76.17%

Change from all-time low

75.91%

Change from open

1.55%

Day's gap

1.84%

Dollar volume

$290,348

High price

$3.93

Low price

$3.82

Monthly RSI

42.03

Open price

$3.87

Position in 52-week range

100%

Premarket change

-1.84%

Premarket close

$3.80

Premarket price

$3.73

Previous close

$3.80

Price vs 150-day SMA

-9.79%

Price vs 20-day SMA

-1.45%

Price vs 200-day SMA

-12.52%

Price vs 50-day SMA

-13.9%

Relative volume

0.51

RSI

43.05

Sharpe ratio

0.06

Sharpe ratio (3Y)

0.2

Sharpe ratio (5Y)

-0.05

Sortino ratio

0.14

Sortino ratio (3Y)

0.37

Sortino ratio (5Y)

0.02

Volume

73.9K

Weekly RSI

44.21

YTD price change

-44.56%

YTD total return

-44.56%

Metric	Value
Float	49.8M
Float percentage	80.9%
Shares change (QoQ)	11.44%
Shares change (YoY)	73.15%
Shares held by insiders	16.75%
Shares held by institutions	54.95%
Shares outstanding	61.6M
Short % of float	6.92%
Short % of shares	5.59%
Short ratio	7.6 days

Metric

Value

Float

49.8M

Float percentage

80.9%

Shares change (QoQ)

11.44%

Shares change (YoY)

73.15%

Shares held by insiders

16.75%

Shares held by institutions

54.95%

Shares outstanding

61.6M

Short % of float

6.92%

Short % of shares

5.59%

Short ratio

7.6 days

TriSalus Life Sciences, Inc. (TLSI)

Price

Financial snapshot

Fair-value bridge

Latest news · TLSI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TLSI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TLSI

Frequently asked questions